ATE131809T1 - Dreizyklische chinoline als antineoplastische wirkstoffe - Google Patents

Dreizyklische chinoline als antineoplastische wirkstoffe

Info

Publication number
ATE131809T1
ATE131809T1 AT90119985T AT90119985T ATE131809T1 AT E131809 T1 ATE131809 T1 AT E131809T1 AT 90119985 T AT90119985 T AT 90119985T AT 90119985 T AT90119985 T AT 90119985T AT E131809 T1 ATE131809 T1 AT E131809T1
Authority
AT
Austria
Prior art keywords
lower alkyl
group
quinolines
actives
antineoplastic
Prior art date
Application number
AT90119985T
Other languages
English (en)
Inventor
Daniel T Chu
Jacob J Plattner
Larry L Klein
Linus L Shen
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE131809T1 publication Critical patent/ATE131809T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C333/00—Derivatives of thiocarbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C333/02—Monothiocarbamic acids; Derivatives thereof
    • C07C333/06—Monothiocarbamic acids; Derivatives thereof having nitrogen atoms of thiocarbamic groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
AT90119985T 1989-10-23 1990-10-18 Dreizyklische chinoline als antineoplastische wirkstoffe ATE131809T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/425,536 US5071848A (en) 1989-10-23 1989-10-23 Tricyclic quinoline antineoplastic agents

Publications (1)

Publication Number Publication Date
ATE131809T1 true ATE131809T1 (de) 1996-01-15

Family

ID=23686982

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90119985T ATE131809T1 (de) 1989-10-23 1990-10-18 Dreizyklische chinoline als antineoplastische wirkstoffe

Country Status (11)

Country Link
US (1) US5071848A (de)
EP (1) EP0424802B1 (de)
JP (1) JPH03167191A (de)
AT (1) ATE131809T1 (de)
CA (1) CA2028246A1 (de)
DE (1) DE69024322T2 (de)
DK (1) DK0424802T3 (de)
ES (1) ES2083990T3 (de)
GR (1) GR3018961T3 (de)
IE (1) IE71688B1 (de)
PT (1) PT95646A (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
WO2006089054A1 (en) * 2005-02-16 2006-08-24 Achillion Pharmaceuticals, Inc. New isothiazoloquinolones and related compounds as anti-infective agents
MX2007005731A (es) * 2004-11-11 2007-07-19 Achillion Pharmaceuticals Inc 8a, 9-dihidro-4a-h-isotiazolo [5,4-b] quinolina-3, 4-diomas y compuestos relacionados como agentes anti-infeccion.
WO2006074317A1 (en) * 2005-01-05 2006-07-13 Achillion Pharmaceuticals, Inc. 1-thia-2,4a-diaza-cyclopenta[b]naphthalene-3,4-diones and related compounds as anti-infective agents
US7199128B2 (en) * 2005-02-02 2007-04-03 Achillion Pharmaceuticals, Inc. 8-N-substituted-2H-isothiazolo[5,4-b]quinolizine-3,4-diones and related compounds as antiinfective agents
CN101287411B (zh) 2005-04-28 2013-03-06 普罗秋斯生物医学公司 药物信息***及其用途
AU2006272571B2 (en) 2005-07-27 2012-03-08 Achillion Pharmaceuticals, Inc. 8-methoxy-9H-isothiazolo[5,4-B]quinoline-3,4-diones and related compounds as anti-infective agents
EP2063905B1 (de) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Behandlungen von lebererkrankungen durch verabreichung von konjugaten aus rezeptor-assoziierten proteinen
DE602009001114D1 (de) 2008-01-25 2011-06-09 Mitsubishi Materials Corp Reaktorreinigungsvorrichtung
PT3395372T (pt) 2009-02-20 2022-05-05 Enhanx Biopharm Inc Sistema de entrega de medicamentos à base de glutationa
AU2010232388A1 (en) * 2009-04-03 2011-10-27 Achillion Pharmaceuticals, Inc. Hydroxythienoquinolones and related compounds as anti-infective agents
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
WO2011031745A1 (en) 2009-09-09 2011-03-17 Achaogen, Inc. Antibacterial fluoroquinolone analogs
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN115650913B (zh) * 2022-10-12 2024-03-01 北京中医药大学 醌式喹啉类化合物及其制备方法和用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767762A (en) * 1985-12-23 1988-08-30 Abbott Laboratories Tricyclic quinoline and naphthyride antibacterials
US4880814A (en) * 1987-11-13 1989-11-14 Abbott Laboratories 7-cycloalkyl naphthyridines
JPH01160985A (ja) * 1987-12-17 1989-06-23 Otsuka Pharmaceut Co Ltd ベンゾヘテロ環化合物
JPH01193275A (ja) * 1988-01-28 1989-08-03 Otsuka Pharmaceut Co Ltd ベンゾヘテロ環化合物
JP2681190B2 (ja) * 1988-04-13 1997-11-26 塩野義製薬株式会社 ピリドン系抗菌剤

Also Published As

Publication number Publication date
US5071848A (en) 1991-12-10
IE903633A1 (en) 1991-04-24
DE69024322T2 (de) 1996-10-31
CA2028246A1 (en) 1991-04-24
DE69024322D1 (de) 1996-02-01
EP0424802A3 (en) 1992-05-06
JPH03167191A (ja) 1991-07-19
IE71688B1 (en) 1997-02-26
EP0424802B1 (de) 1995-12-20
PT95646A (pt) 1991-09-13
GR3018961T3 (en) 1996-05-31
EP0424802A2 (de) 1991-05-02
DK0424802T3 (da) 1996-04-22
ES2083990T3 (es) 1996-05-01

Similar Documents

Publication Publication Date Title
ATE131809T1 (de) Dreizyklische chinoline als antineoplastische wirkstoffe
ATE301116T1 (de) Aminopyrazol derivate
NO863980L (no) Fremgangsmaate for fremstilling av kinazolinderivater.
DE69012512D1 (de) Heterocyclische Oxy-phenoxy-Essigsäurederivate und ihre Verwendung als Herbizide.
FI905418A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 4- tai 6-substituoitujen trimetyylipyrrolo/2,3-b/indolikarbamaattien valmistamiseksi
ATE105285T1 (de) Salicylaldehyd- und salicylsaeurederivate sowie deren schwefelanaloge, verfahren zu ihrer herstellung und ihre verwendung als herbizide und bioregulatoren.
FI862757A (fi) Pyridonkarbonsyraderivat och foerfarande foer framstaellning av dessa.
DK519985D0 (da) Quinoloncarboxylsyrederivater, fremgangsmaade til fremstilling deraf og antibakterielt middel indeholdende saadanne derivater
DK0526588T3 (da) Heterocykliske forbindelser, deres fremstilling og anvendelse
DK283984D0 (da) Benzodiazepinderivater og fremgangsmaade til fremstilling deraf
NO914003D0 (no) Fremgangsmaate for fremstilling av hydroxyalkylkinolinethersyrer
DK0385224T3 (da) Substituerede N-hydroxypyraxoler og fungicider der indeholder disse forbindelser
SE8300580D0 (sv) Substituerade 1,3,4-tiadiazolo (3,2-a)pyrimidiner och forfarande for deras framstellning
FI912499A0 (fi) Pyrido/3,4-b/pyrrolo/1,2-e//1,4,5/ oxadiazepiner och daermed naerbeslaektade analoger, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
NO800033L (no) 4-aminopyridin, fremgangsmaate til deres fremstilling og legemiddel inneholdende disse
DE3883434D1 (de) Mitomycinanaloge, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen.
ATE121937T1 (de) Verwendung von 2h-1,2,4-benzothiadiazin-3(4h)- thion-1,1-dioxiden als antivirale arzneimittel.
HUT47293A (en) Process for producing pyrimido-oxazine derivatives

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee